secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001193125-26-041852
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq Listing Council stays BCAB delisting, calls review of Feb 6 non-compliance determination
--------------------------------------------------------------------------------

- Nasdaq determined Feb 6 to delist BCAB for non-compliance with bid price ($1) and stockholders' equity ($2.5M) requirements.
- On Feb 8, Nasdaq Listing Council called review of delist decision and stayed suspension; BCAB continues trading on Nasdaq.
- Company asserts Nasdaq's delay and policy change on super-voting stock caused irreparable harm.
- Listing Council review may take weeks to months; no assurance stock will remain listed after review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526041852/0001193125-26-041852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526041852/d317360d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-041852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer